Perrigo (PRGO) Director Reports Share Sale and 1,263 RSU Grant
Rhea-AI Filing Summary
Bradley A. Alford, a director of Perrigo Company plc (PRGO), reported a sale and a grant on Form 4. The filing shows a disposition of 41,160.148 ordinary shares on 09/12/2025. The filing also reports acquisition of 1,263 Restricted Stock Units (RSUs) on 09/12/2025, each representing a contingent right to one ordinary share, with vesting on 12 September 2026. The RSUs are held directly. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Alford on 09/15/2025. The document does not state a sale price, remaining total ordinary shares owned after the sale, or the reason for the transactions.
Positive
- Grant of 1,263 Restricted Stock Units with an explicit vesting date of 12 September 2026, aligning director compensation with shareholder interests
Negative
- Disposition of 41,160.148 ordinary shares by a director on 09/12/2025, which reduces insider ownership stake
- Filing does not disclose sale price or post-transaction total holdings, limiting transparency for assessing materiality
Insights
TL;DR: Director sold a sizable block of shares and received a modest RSU grant; transactions appear routine but reduce insider ownership.
The reported disposition of 41,160.148 ordinary shares on 09/12/2025 is a material insider sale by a director in absolute terms, while the grant of 1,263 RSUs vests on 12 September 2026 and increases future share-based compensation exposure. The filing does not disclose sale price or post-transaction shareholdings, limiting assessment of proceeds or percentage ownership change. Without price or context, the market impact is unclear; this appears to be a standard insider reporting event rather than a disclosure of corporate news.
TL;DR: Routine director reporting: a share disposition and standard RSU award, with clear vesting date but no explanatory context.
The Form 4 correctly identifies Mr. Alford as a director and shows both a disposal and a grant on the same date. The RSU vesting date is explicitly stated. The filing lacks commentary on whether the sale was part of a pre-arranged plan or for personal liquidity, and does not show resulting beneficial ownership levels. From a governance standpoint, the items are properly reported but additional disclosure would aid investor interpretation.